当前位置:首页 - 行情中心 - 天坛生物(600161) - 财务分析 - 现金流量表

天坛生物

(600161)

  

流通市值:261.61亿  总市值:261.61亿
流通股本:19.77亿   总股本:19.77亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金991,221,205.84,734,373,938.473,075,023,127.551,736,558,359.18
  收到其他与经营活动有关的现金36,105,899.8981,028,757.383,623,172.2149,939,140.28
  经营活动现金流入小计1,027,327,105.694,815,402,695.773,158,646,299.761,786,497,499.46
  购买商品、接受劳务支付的现金543,382,939.132,267,585,618.381,611,489,389.791,039,889,364.45
  支付给职工以及为职工支付的现金281,149,427.581,212,164,096.4669,693,580.99445,464,366.1
  支付的各项税费174,446,993.57767,125,365.15586,001,241.1399,920,918.5
  支付其他与经营活动有关的现金43,855,941.44229,780,957.21174,567,059.81103,127,400.53
  经营活动现金流出小计1,042,835,301.724,476,656,037.143,041,751,271.691,988,402,049.58
  经营活动产生的现金流量净额-15,508,196.03338,746,658.63116,895,028.07-201,904,550.12
二、投资活动产生的现金流量:
  收回投资收到的现金3,772,865.94---
  取得投资收益收到的现金26,542,489.8337,196,956.9637,100,956.9637,100,956.96
  处置固定资产、无形资产和其他长期资产收回的现金净额13,470339,337.03138,228.379,930.7
  处置子公司及其他营业单位收到的现金净额5,134,763.93---
  收到的其他与投资活动有关的现金506,000,000709,000,000700,000,000700,000,000
  投资活动现金流入小计541,463,589.7746,536,293.99737,239,185.26737,180,887.66
  购建固定资产、无形资产和其他长期资产支付的现金187,146,547.77605,531,434.31450,530,338.98325,460,519.56
  支付其他与投资活动有关的现金800,000,00016,650,000--
  投资活动现金流出小计987,146,547.77622,181,434.31450,530,338.98325,460,519.56
  投资活动产生的现金流量净额-445,682,958.07124,354,859.68286,708,846.28411,720,368.1
三、筹资活动产生的现金流量:
  取得借款收到的现金86,953,347.1286,925,081.38252,966,301.4242,137,862.63
  筹资活动现金流入小计86,953,347.1286,925,081.38252,966,301.4242,137,862.63
  分配股利、利润或偿付利息支付的现金-706,612,364.61706,402,398.36304,247,963.18
  其中:子公司支付给少数股东的股利、利润-212,269,503.11212,269,503.11107,143,523.23
  支付其他与筹资活动有关的现金1,101,139.6722,708,405.5718,726,597.110,930,606.63
  筹资活动现金流出小计1,101,139.67729,320,770.18725,128,995.46315,178,569.81
  筹资活动产生的现金流量净额85,852,207.43-442,395,688.8-472,162,694.04-273,040,707.18
四、汇率变动对现金及现金等价物的影响-14,958.93-28,934.14-9,499.67-2,279.48
五、现金及现金等价物净增加额-375,353,905.620,676,895.37-68,568,319.36-63,227,168.68
  加:期初现金及现金等价物余额1,443,597,800.411,422,920,905.041,422,920,905.041,422,920,905.04
  期末现金及现金等价物余额1,068,243,894.811,443,597,800.411,354,352,585.681,359,693,736.36
补充资料:
  净利润-1,489,882,179.7-865,800,086.14
  资产减值准备-19,110,612.28-33,550,584.65
  固定资产和投资性房地产折旧-348,834,129.26-163,520,008.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-348,834,129.26-163,520,008.34
  无形资产摊销-76,618,593.93-37,830,420.75
  长期待摊费用摊销-32,280,975.62-16,831,522.75
  处置固定资产、无形资产和其他长期资产的损失--104,452.59--204,679.09
  固定资产报废损失-2,875,975.18-54,096.04
  财务费用-7,364,956.02-4,340,269.9
  投资损失--29,398,010.78--22,432,891.35
  递延所得税--12,871,040.86--10,792,107.38
  其中:递延所得税资产减少--14,651,807.57--4,514,683.67
    递延所得税负债增加-1,780,766.71--6,277,423.71
  存货的减少--172,036,268.91--40,628,592.84
  经营性应收项目的减少--1,375,668,968.71--1,340,914,398.19
  经营性应付项目的增加--113,339,500.64-78,271,390.42
  现金的期末余额-1,443,597,800.41-1,359,693,736.36
  减:现金的期初余额-1,422,920,905.04-1,422,920,905.04
  现金及现金等价物的净增加额-20,676,895.37--63,227,168.68
公告日期2026-04-302026-03-282025-10-252025-08-22
审计意见(境内)标准无保留意见
TOP↑